N
NeuroBo Pharmaceuticals D
D
NRBO
2.58000
USD
-0.08
(-3.01%)
مفتوح الان
حجم التداول
749
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
21,895,934
المقالات
العنوان: NeuroBo Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.